This would suggest that the modifications remaining in H. volcanii tRNA are also critical for functions that cannot be replaced by salt and we are currently mutating all the corresponding genes to address the functional of these modifications in vivo.
The PI3K p110α catalytic subunit (PIK3CA) gene is currently the most frequently mutated kinase in human cancer.
Furthermore, there is currently no drug that targets mutated IDH, although this remains an area of active research.
In addition Nilotinib, a tyrosine kinase inhibitor used in imatinib-resistant chronic myelogenous leukaemia (CML), seems another promising agent in the treatment of KIT mutated metastatic melanoma and is currently under clinical investigation.
The tumour suppressor gene PTEN is currently recognised as one of the most frequently mutated genes in human cancers.
Combination therapy with BRAF and MEK inhibition is currently in clinical development for the treatment of BRAF mutated malignant melanoma [ 39].
A study in the adjuvant setting is currently evaluating the value of 1 year of adjuvant olaparib in BRCA1 mutated patients (NCT02032823) and a relatively large number of young patients will likely enroll.
The gene is mutated in a proportion of later-onset PD, but it is currently uncertain whether single-copy deletions in fact predispose to this condition.
"It is currently dysfunctional".
